WELL Health Technologies (TSX:WELL) Total Stockholders Equity : C$867.6 Mil (As of Dec. 2024)

View and export this data going back to 2012. Start your Free Trial

What is WELL Health Technologies Total Stockholders Equity?

WELL Health Technologies's Total Stockholders Equity for the quarter that ended in Dec. 2024 was C$867.6 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. WELL Health Technologies's Book Value per Share for the quarter that ended in Dec. 2024 was C$3.48. The ratio of a company's debt over equity can be used to measure how leveraged this company is. WELL Health Technologies's Debt-to-Equity for the quarter that ended in Dec. 2024 was 0.49.

WELL Health Technologies Total Stockholders Equity Historical Data

The historical data trend for WELL Health Technologies's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WELL Health Technologies Total Stockholders Equity Chart

WELL Health Technologies Annual Data

Trend

Oct15

Oct16

Oct17

Oct18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Stockholders Equity

Get a 7-Day Free Trial

216.65

617.85

732.34

767.67

867.61

WELL Health Technologies Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Stockholders Equity	Get a 7-Day Free Trial															767.67	810.84	935.02	847.12	867.61

WELL Health Technologies (TSX:WELL) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

WELL Health Technologies's Book Value per Share for the quarter that ended in Dec. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(867.607	-	0)	/	249.092
	=	3.48

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

WELL Health Technologies's Debt-to-Equity for the quarter that ended in Dec. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(28.035	+	397.054)	/	867.607
	=	0.49

WELL Health Technologies Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of WELL Health Technologies's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

WELL Health Technologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » WELL Health Technologies Corp (TSX:WELL) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

WHTCF:USA W7V:Germany

Address

375 Water Street, Suite 550, Vancouver, BC, CAN, V6B 5C6

Website

https://www.well.company

WELL Health Technologies Corp is a practitioner-focused digital healthcare company. It has seven reportable segments that are grouped into three key business units: Canadian Patient Services that includes Primary and Specialized MyHealth. WELL Health USA Patient Services includes Primary Circle Medica, Primary WISP, Specialized CRH Medical, and Specialized Provider Staffing and SaaS and Technology Services. It generates the majority of its revenue from Well Health USA Patient and Provider Services unit.

Executives

Eva Fong	Senior Officer
Hamed Shahbazi	10% Security Holder, Director, Senior Officer
John Kim	Director
Amir Javidan	Senior Officer
Thomas Craig Liston	Director
Tara Mccarville	Director
Kenneth Anthony Cawkell	Director
Sybil E Jen Lau	Director
Well Health Technologies Corp.	Issuer
Arjun Kumar	Senior Officer
Brian Eric Levinkind	Director